Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Endosonics

This article was originally published in The Gray Sheet

Executive Summary

Rheinhard Warnking joins company as president, COO and member of the board. Warnking, who previously was president and CEO of Acoustic Imaging Technology, Inc., replaces Michael Henson as president of the company. Henson will continue as CEO and chairman of the board. The COO position is newly established. In addition, David Robertson will become chief financial officer and vice president, assuming the posts from Dana Nickell, who retains the position of vice president, business development. Endosonics also announced first quarter 1993 sales revenues of $1.3 mil., up from $1.2 mil. in the first quarter of 1993.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT000530

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel